AtCor Medical - Analysts Reports

CONTACT US SITE MAP SEARCH

Home / Investors / Analysts' Reports

Analysts' Reports

Analysts' Reports

RB Milestone Group

27 October 2009

Strong Growth Prospects with Multi-market Opportunities of $2.1 billion

Click here to access RB Milestone Group portal for further reports and updates

Taylor Collison

12 January 2012

Major New US Advocacy for Central Pressure Assessment

18 February 2011

1H11 NPAT Loss of $1.4m

20 August 2010

Navigated a Tough Year; Expansion of Reimbursement to Continue

8 July 2010

US$1.8m Contract, Further Expansion of Coverage in Midwest

3 June 2010

5m Covered Lives Added in Midwest

19 February 2010

Average 1H, But CP Thematic Growing in Strength

29 October 2009

Central Pressure Paradigm Drawing Ever Closer

21 August 2009

No Surprises Post July FY09 Result Preview; Pharma Contracts Remain the Driver

27 July 2009

Grows FY09 Product Sales by 74%

19 May 2009

Second FY Sales Upgrade Builds Confidence

15 April 2009

Additional US$0.8m in Pharma Contracts Underscores Defensive Model

2 April 2009

New Application Potential for SphygmoCor

20 February 2009

1H09 Maiden NPAT of $0.2m; Outlook Remains Solid

14 November 2008

Major Clinical Endorsement Continues; FY09 Sales Upgrade

4 November 2008

US$4.2m in Pharma Trial Contracts since June

10 June 2008

Central Pressure Measurement: The Next Major Medical Paradigm Shift?

21 May 2008

Russian Approval; Major Clinical Evidence Underpins SphygmoCor® Opportunity

11 March 2008

Initiating Coverage; Valuation Metrics Too Attractive to Ignore